US Patent Issued to Industry-University Cooperation Foundation Hanyang University, Konkuk University Glocal Industry-Academic Collaboration Foundation, Korea National University of Education Industry-Academy Cooperation Foundation on April 21 for "CP2C-targeting peptide-based anticancer agent" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,453, issued on April 21, was assigned to Industry-University Cooperation Foundation Hanyang University (Seoul, South Korea), Konkuk University Glocal Industry-Academic Collaboration Foundation (Chungju-si, South Korea) and Korea National University of Education Industry-Academy Cooperation Foundation (Cheongwon-gun, South Korea).

"CP2C-targeting peptide-based anticancer agent" was invented by Chul Geun Kim (Seoul, South Korea), Min Young Kim (Seoul, South Korea), Chan Gil Kim (Chungju-si, South Korea), Seung Han Son (Incheon, South Korea), Ji Sook Kim (Uijeongbu-si, South Korea), Sung Woo Choi (Gimpo-si, South Korea), Seol Eui Lee (Seoul, South Korea), Min Sung Chung (Seoul, Sout...